- Suspected mould exposure: environmental or building-related exposure concerns.
- Respiratory symptoms: nasal congestion, coughing or sinus irritation.
- Fatigue: persistent tiredness without clear explanation.
- Neurological symptoms: headaches, concentration difficulties or dizziness.
- Immune symptoms: recurrent infections or altered immune response.
- Gastrointestinal symptoms: digestive discomfort or appetite changes.
- Occupational exposure: work in damp or water-damaged environments.
- Environmental illness history: symptoms associated with indoor air quality issues.
Overview
The Mycotoxin Profile - RealTime measures a panel of mycotoxin metabolites in urine using advanced analytical methods. The profile focuses on 16 metabolites representing five major mycotoxin families, including aflatoxins, trichothecenes and other commonly encountered mycotoxins such as ochratoxin A, gliotoxin and zearalenone.
Clinically, this test may be useful when exploring symptoms or histories suggestive of environmental mould exposure. Measuring mycotoxin metabolites in urine provides insight into recent exposure patterns and can be considered alongside environmental assessments, symptom history and other laboratory findings.
Practitioners typically interpret results in the context of exposure history, living or working environments, dietary factors and additional investigations. When reviewed in context, the test can support informed discussions with clients about mould-related exposure patterns.
Practical
Specimen
FMV Urine (minimum 7ml)
Container
Patient preparation
- Collect a first-morning void specimen, meaning the first urination collected after a 6-8 hour period of time.
- Collect a mid-stream urine catch, filling 1/2 of the collection cup.
- Specimens should be sent to the lab within 48 hours of collection. If samples can not be shipped immediately, liquid samples should be frozen until the time of shipment.